Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request, 87375-87376 [2024-25503]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 31, 2024.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development, Attention:
Document Identifier/OMB Control
Number: l, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
VerDate Sep<11>2014
16:47 Oct 31, 2024
Jkt 265001
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10520 Marketplace Quality
Standards
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires Federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collections
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Marketplace
Quality Standards; Use: The Patient
Protection and Affordable Care Act
establishes requirements to support the
delivery of quality health care coverage
for health insurance issuers offering
QHPs in Exchanges. Section 1311(c)(3)
of the Patient Protection and Affordable
Care Act directs the Secretary to
develop a system to rate QHPs on the
basis of quality and price and requires
Exchanges to display this quality rating
information on their respective
websites. Section 1311(c)(4) of the
Patient Protection and Affordable Care
Act requires the Secretary to develop an
enrollee satisfaction survey system to
assess enrollee experience with each
QHP (with more than 500 enrollees in
the previous year) offered through an
Exchange. Section 1311(h) requires
QHPs to contract with certain hospitals
that meet specific patient safety and
health care quality standards beginning
January 1, 2015.
This collection of information is
necessary to provide adequate and
timely health care quality information
for consumers, regulators, and
Exchanges in the initial years of
Exchange implementation. It is also
necessary to collect information to
appropriately monitor and provide a
process for a survey vendor to appeal
HHS’ decision to not approve a QHP
Enrollee Survey vendor application.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
87375
Form Number: CMS–10114 (OMB
control number: 0938–1249); Frequency:
Annually; Affected Public: Public sector
(Individuals and Households), Private
sector (Business or other for-profits and
Not-for-profit institutions); Number of
Respondents: 380; Total Annual
Responses: 380; Total Annual Hours:
138,112. (For policy questions regarding
this collection contact Preeti Hands at
301–492–5144.)
William N. Parham III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–25505 Filed 10–31–24; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10398 #86]
Medicaid and Children’s Health
Insurance Program (CHIP) Generic
Information Collection Activities:
Proposed Collection; Comment
Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
On May 28, 2010, the Office
of Management and Budget (OMB)
issued Paperwork Reduction Act (PRA)
guidance related to the ‘‘generic’’
clearance process. Generally, this is an
expedited process by which agencies
may obtain OMB’s approval of
collection of information requests that
are ‘‘usually voluntary, low-burden, and
uncontroversial collections,’’ do not
raise any substantive or policy issues,
and do not require policy or
methodological review. The process
requires the submission of an
overarching plan that defines the scope
of the individual collections that would
fall under its umbrella. This Federal
Register notice seeks public comment
on one or more of our collection of
information requests that we believe are
generic and fall within the scope of the
umbrella. Interested persons are invited
to submit comments regarding our
burden estimates or any other aspect of
this collection of information,
including: the necessity and utility of
the proposed information collection for
the proper performance of the agency’s
functions, the accuracy of the estimated
burden, ways to enhance the quality,
utility and clarity of the information to
be collected, and the use of automated
SUMMARY:
E:\FR\FM\01NON1.SGM
01NON1
87376
Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
November 15, 2024.
ADDRESSES: When commenting, please
reference the applicable form number
(CMS–10398 #86) and the OMB control
number (0938–1148). To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development, Attention:
CMS–10398 #86/OMB control number:
0938–1148, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
medicare/regulations-guidance/
legislation/paperwork-reduction-act1995/pra-listing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at 410–786–4669.
SUPPLEMENTARY INFORMATION:
Following is a summary of the use
and burden associated with the subject
information collection(s). More detailed
information can be found in the
collection’s supporting statement and
associated materials (see ADDRESSES).
Generic Information Collection
1. Title of Information Collection:
Section 1115 Reentry Demonstration
Initiative; Type of Information
Collection Request: New information
collection request; Use: On April 17,
2023, CMS released a State Medicaid
Directors Letter (SMDL #23–003)
announcing a demonstration
opportunity to support community
reentry and improve care transitions for
individuals who are incarcerated and
who are otherwise eligible for Medicaid
to receive medical assistance under title
XIX. The Section 1115 Reentry
Demonstration Opportunity (hereinafter,
‘‘the Reentry Demonstration Initiative’’)
will allow states to offer coverage for
VerDate Sep<11>2014
16:47 Oct 31, 2024
Jkt 265001
certain pre-release services for up to 90
days prior to the individual’s expected
release date that could not otherwise be
covered by Medicaid due to the
Medicaid inmate exclusion policy. The
provision is consistent with section
5032 of the Substance Use Disorder
Prevention that Promotes Opioid
Recovery and Treatment for Patients
and Communities Act (SUPPORT Act)
(Pub. L. 115–271), ‘‘Promoting State
Innovations to Ease Transitions
Integration to the Community for
Certain Individuals.’’
States applying for the Reentry
Demonstration Initiative must provide a
minimum set of pre-release services
called the ‘‘pre-release benefit package.’’
The benefit package aims to improve
transitions for individuals being
released from jails or prisons and
returning to their communities. The
benefit package must include: (1) case
management to assess and address
physical and behavioral health needs
and health-related social needs; and (2)
medication-assisted treatment services
for all types of substance use disorders
as clinically appropriate, with
accompanying counseling. Also
required in the minimum set of services
is a 30-day supply of all prescription
medications that have been prescribed
for the beneficiary.
This collection of information request
includes three templates that are
intended to expedite CMS’s review of
reentry demonstration initiative
applications and to support state
implementation planning and related
transparency by standardizing the
presentation of key information
necessary for approvals, thereby
reducing rounds of clarifying questions
with state applicants. The three
templates include the: (1) reentry
demonstration initiative preprint, (2)
reentry implementation plan template,
and (3) reentry budget neutrality
formulation workbook. The templates
are strongly encouraged but optional
and described in the following section.
Form Number: CMS–10398 #86 (OMB
control number: 0938–1148); Frequency:
Annual and on occasion; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
10; Total Annual Responses: 30; Total
Annual Hours: 300. (For policy
questions regarding this collection
contact: Raven Smith at 410–786–3731.)
William N. Parham III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–25503 Filed 10–31–24; 8:45 am]
BILLING CODE 4120–01–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–3575]
Reauthorization of the Over-TheCounter Monograph Drug User Fee
Program; Public Meeting; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is hosting a public meeting to
discuss proposed recommendations for
the reauthorization of the Over-TheCounter [OTC] Monograph Drug User
Fee Program (OMUFA) for fiscal years
(FYs) 2026 through 2030. Under
OMUFA, FDA collects user fees to
support OTC monograph drug activities.
The current legislative authority for
OMUFA expires September 30, 2025. At
that time, new legislation will be
required to reauthorize OMUFA for
future fiscal years. Following
negotiations with the regulated industry
and consultation with interested
members of the public, the Federal
Food, Drug, and Cosmetic Act (FD&C
Act) directs FDA to publish
recommendations for the
reauthorization of the OMUFA program
in the Federal Register, provide for a
period of 30 days for the public to
provide written comments on such
recommendations, and hold a meeting
at which the public may present its
views on such recommendations. FDA
will then consider such public views
and comments and revise such
recommendations as necessary.
DATES: The public meeting will be held
on November 20, 2024, from 9 a.m. to
12:30 p.m. Submit either electronic or
written comments on this public
meeting by December 20, 2024. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: The public meeting is
scheduled to be held at the FDA White
Oak Campus, 10903 New Hampshire
Ave., Bldg. 31 Conference Center, Rm.
1503, Silver Spring, MD 20993.
Entrance for the public meeting
participants (non-FDA employees) is
through Building 1 where routine
security check procedures will be
performed. For parking and security
information, please refer to https://
www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
SUMMARY:
E:\FR\FM\01NON1.SGM
01NON1
]]>Agencies
[Federal Register Volume 89, Number 212 (Friday, November 1, 2024)]
[Notices]
[Pages 87375-87376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25503]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10398 #86]
Medicaid and Children's Health Insurance Program (CHIP) Generic
Information Collection Activities: Proposed Collection; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: On May 28, 2010, the Office of Management and Budget (OMB)
issued Paperwork Reduction Act (PRA) guidance related to the
``generic'' clearance process. Generally, this is an expedited process
by which agencies may obtain OMB's approval of collection of
information requests that are ``usually voluntary, low-burden, and
uncontroversial collections,'' do not raise any substantive or policy
issues, and do not require policy or methodological review. The process
requires the submission of an overarching plan that defines the scope
of the individual collections that would fall under its umbrella. This
Federal Register notice seeks public comment on one or more of our
collection of information requests that we believe are generic and fall
within the scope of the umbrella. Interested persons are invited to
submit comments regarding our burden estimates or any other aspect of
this collection of information, including: the necessity and utility of
the proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility and clarity of the information to be
collected, and the use of automated
[[Page 87376]]
collection techniques or other forms of information technology to
minimize the information collection burden.
DATES: Comments must be received by November 15, 2024.
ADDRESSES: When commenting, please reference the applicable form number
(CMS-10398 #86) and the OMB control number (0938-1148). To be assured
consideration, comments and recommendations must be submitted in any
one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address:
CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: CMS-10398 #86/OMB
control number: 0938-1148, Room C4-26-05, 7500 Security Boulevard,
Baltimore, Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/medicare/regulations-guidance/legislation/paperwork-reduction-act-1995/pra-listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at 410-786-4669.
SUPPLEMENTARY INFORMATION:
Following is a summary of the use and burden associated with the
subject information collection(s). More detailed information can be
found in the collection's supporting statement and associated materials
(see ADDRESSES).
Generic Information Collection
1. Title of Information Collection: Section 1115 Reentry
Demonstration Initiative; Type of Information Collection Request: New
information collection request; Use: On April 17, 2023, CMS released a
State Medicaid Directors Letter (SMDL #23-003) announcing a
demonstration opportunity to support community reentry and improve care
transitions for individuals who are incarcerated and who are otherwise
eligible for Medicaid to receive medical assistance under title XIX.
The Section 1115 Reentry Demonstration Opportunity (hereinafter, ``the
Reentry Demonstration Initiative'') will allow states to offer coverage
for certain pre-release services for up to 90 days prior to the
individual's expected release date that could not otherwise be covered
by Medicaid due to the Medicaid inmate exclusion policy. The provision
is consistent with section 5032 of the Substance Use Disorder
Prevention that Promotes Opioid Recovery and Treatment for Patients and
Communities Act (SUPPORT Act) (Pub. L. 115-271), ``Promoting State
Innovations to Ease Transitions Integration to the Community for
Certain Individuals.''
States applying for the Reentry Demonstration Initiative must
provide a minimum set of pre-release services called the ``pre-release
benefit package.'' The benefit package aims to improve transitions for
individuals being released from jails or prisons and returning to their
communities. The benefit package must include: (1) case management to
assess and address physical and behavioral health needs and health-
related social needs; and (2) medication-assisted treatment services
for all types of substance use disorders as clinically appropriate,
with accompanying counseling. Also required in the minimum set of
services is a 30-day supply of all prescription medications that have
been prescribed for the beneficiary.
This collection of information request includes three templates
that are intended to expedite CMS's review of reentry demonstration
initiative applications and to support state implementation planning
and related transparency by standardizing the presentation of key
information necessary for approvals, thereby reducing rounds of
clarifying questions with state applicants. The three templates include
the: (1) reentry demonstration initiative preprint, (2) reentry
implementation plan template, and (3) reentry budget neutrality
formulation workbook. The templates are strongly encouraged but
optional and described in the following section.
Form Number: CMS-10398 #86 (OMB control number: 0938-1148);
Frequency: Annual and on occasion; Affected Public: State, Local, or
Tribal Governments; Number of Respondents: 10; Total Annual Responses:
30; Total Annual Hours: 300. (For policy questions regarding this
collection contact: Raven Smith at 410-786-3731.)
William N. Parham III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-25503 Filed 10-31-24; 8:45 am]
BILLING CODE 4120-01-P
